Status | Study |
Completed |
Study Name: Study of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal Syndrome Condition: Brain and Central Nervous System Tumors Breast Cancer Meta Date: 2009-07-11 Interventions: Other: diagnostic laboratory biomarker analysis |
Completed |
Study Name: A Pilot Study of Bevacizumab for Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2009-06-18 Interventions: Drug: Bevacizumab 10 mg/kg by vein over about 1 hour, every 2 weeks. |
Completed |
Study Name: Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis. Condition: Solid Tumour Neoplastic Meningitis Brain Metastases Date: 2009-03-02 Interventions: Drug: Whole Brain Radio Therapy (WBRT) with sequential Depocyte |
Terminated |
Study Name: A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer Condition: Leptomeningeal Carcinomatosis Non-small Cell Lung Cancer Date: 2009-01-24 Interventions: Drug: Erlotinib Erlotinib 150mg/day |
Completed |
Study Name: Phase 1 Intrathecal Topotecan for Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2007-12-21 Interventions: Drug: Topotecan |
Terminated |
Study Name: A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis Condition: Leptomeningeal Carcinomatosis Date: 2007-09-07 Interventions: Drug: RTA 744 Aqueous solution of RTA 744 is packaged in 5 ml vials - 1 mg/ ml. The drug is mixed in D10 |
Terminated |
Study Name: DepoCyt for Active Lymphomatous or Leukemic Meningitis Condition: Neoplastic Meningitis Lymphoma, B Cell Date: 2007-08-31 Interventions: Drug: cytarabine liposome injection 50 mg intrathecal every 14 days for 8 doses, then every 28 days for |
Terminated |
Study Name: DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2007-08-13 Interventions: Drug: DepoCyt Starting dose of |
Terminated |
Study Name: RTA 744 Injection in Patients With Leptomeningeal Disease Condition: Neoplastic Meningitis Solid Tumor Date: 2007-08-03 Interventions: Drug: RTA 744 4.8 mg/m^2 by vein Over 2 Hours On Days 1-3. |
Withdrawn |
Study Name: High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations Condition: Non-Small Cell Lung Cancer Date: 2006-09-06 Interventions: Drug: Gefitinib On days 1-14 gefitinib will be taken orally daily at either 750, 1000, or 1250mg (depend |